OpenURL Connection Search

Select item for more details and to access through your institution.

Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.
Published in:
1988
By:
- Cognetti, Francesco;
- Carlini, Paolo;
- Ruggeri, Enzo Maria;
- Impiombato, Fabrizio Ambesi;
- Vecchio, Maria Rosaria Del;
- Pinnaro, Paola;
- Giannarelli, Diana;
- Perrino, Annibale;
- Cognetti, F;
- Pinnarò, P;
- Carlini, P;
- Ruggeri, E M;
- Ambesi Impiombato, F;
- Del Vecchio, M R;
- Giannarelli, D;
- Perrino, A
Publication type:
journal article
Impact of previous corticosteroid exposure on outcomes of patients receiving immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective observational study.
Published in:
2022
By:
- Nelli, F.;
- Virtuoso, A.;
- Berrios, J. R. Giron;
- Giannarelli, D.;
- Fabbri, A.;
- Marrucci, E.;
- Ruggeri, E. M.
Publication type:
journal article
Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study.
Published in:
2001
By:
- Nardi, Mario;
- de Marco, Salvatore;
- Fabi, Alessandra;
- Aloe, Alessandra;
- Magnani, Elena;
- Pacetti, Umberto;
- Carlini, Paolo;
- Ruggeri, Enzo Maria;
- Cognetti, Francesco;
- Nardi, M;
- De Marco, S;
- Fabi, A;
- Aloe, A;
- Magnani, E;
- Pacetti, U;
- Carlini, P;
- Ruggeri, E M;
- Cognetti, F
Publication type:
journal article
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.
Published in:
2006
By:
- Ferretti, G.;
- Bria, E.;
- Giannarelli, D.;
- Felici, A.;
- Papaldo, P.;
- Fabi, A.;
- Di Cosimo, S.;
- Ruggeri, E. M.;
- Milella, M.;
- Ciccarese, M.;
- Cecere, F. L.;
- Gelibter, A.;
- Nuzzo, C.;
- Cognetti, F.;
- Terzoli, E.;
- Carlini, P.
Publication type:
journal article

Found: 4

Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.

Impact of previous corticosteroid exposure on outcomes of patients receiving immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective observational study.

Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study.

Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.